AzTrials
AzTrials

High MyopiaLOVE-WHNCT06162234

Wuhan High Myopia Study

An observational study of High Myopia, run by Renmin Hospital of Wuhan University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The study aims to observe the long-term changes of ocular(especially fundus) structure and visual function in patients with high myopia, so as to provide evidence for the prevention, diagnosis and prognosis of high myopia. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
High Myopia
What is being tested?
observational
How many people
1,000 participants
Where
1 siteChina
Study dates
25 Dec 2023to 1 Sep 2027
How long will I take part?
4 Years
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: First-year college student from Wuhan University

Who may be able to join

  • Voluntarily sign informed consent;
  • Commit to follow the research procedures and cooperate with the whole process of the study;
  • Age ≥18 years old;
  • Best corrected visual acuity ≥0.1;
  • Spherical Equivalent Refraction≤-6.00D or axial length ≥26mm in high myopia group;

Who cannot join

  • Unable or unwilling to sign informed consent;
  • Unable to cooperate with the examination;
  • Astigmatism ≤-1.5D;
  • Patients with refractive interstitial opacity so that fundus images cannot be collected;
  • Patients with fundus diseases such as diabetic retinopathy, hypertensive retinopathy, age-related macular degeneration, retinal vein obstruction, retinal artery obstruction, etc

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site, 1 recruiting
  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, 430060

    CZ Chen, PHD, +86 13072765173, whuchenchzh@163.com

    QY Wu, PHD, +86

    Recruiting

Other trials in China

About this study

Official title: Long Term Observation of Ocular Structure and Visual Function in Eyes With High Myopia:Wuhan High Myopia Study

The study aims to observe the long-term changes of ocular(especially fundus) structure and visual function in patients with high myopia, so as to provide evidence for the prevention, diagnosis and prognosis of high myopia.

Read the detailed description

High myopia is defined as a refractive error of ≤-6.00D or an axial length greater than 26mm. In recent years, the population of highly myopic individuals has been increasing rapidly. Scholars predict that if no effective interventions are taken, the global incidence rate of myopia is expected to increase from 22.9% in 2000 to 49.8% in 2050, and the visual impairment caused by high myopia will be seven times higher than in 2000 on a global scale. In China, a survey conducted by the National Health Commission in 2018 found that highly myopic students accounted for 21.9% of third-year high school students, indicating that high myopia has become a major public health issue due to its prevalence among younger populations.

In recent years, with the development of ocular imaging technologies such as optical coherence tomography (OCT) and corresponding image analysis techniques, high-resolution, non-invasive, fast and in vivo retinal imaging has become more accessible. This has led to the discovery and exploration of various imaging parameters related to optic disc and macula changes in highly myopic patients. We will conduct a 4 years prospective cohort study in the population of 1000 high myopia and controls which have established in mainly college student population, using the latest OCT-A and SS-OCT to observe the long-term changes of fundus structure combined with visual function in patients with high myopia , and explore biomarkers affecting visual function, so as to provide basis for prevention and control of high myopia and prognosis.

Conditions
High Myopia
Being tested
observational
Keywords
ocular biometric parameters, Refractive Errors
Medical subject headings
Refractive Errors

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • observationalOther

    none (observational study)

Study groups in NCT06162234
Study groupRoleWhat they receive
entire cohortentire cohort made up of high myopia patients(observational study)
Receives: Other: observational

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Myopic optic nerve changes

    Changes in the optic nerve head morphology and blood supply which are supposed to be related with high myopia,examined by fundus photography,OCT,OCTA,etc

    Measured: Baseline and 6 months and 1,2,3,4years

  2. Progression of axial length (AL)

    Subjects' axial length and its progression collected by IOL master 700

    Measured: Baseline and 6 months and 1,2,3,4years

  3. Incidence and progression of visual field (VF) defects

    Variety and progression of visual field defects collected by Humphrey 860 perimetry

    Measured: Baseline and 6 months and 1,2,3,4years

  4. Loss of best corrected visual acuity(BCVA)

    Incidence of BCVA loss collected by subjective optometry

    Measured: Baseline and 6 months and 1,2,3,4years

  5. Incidence and progression of myopic maculopathy

    Collected by color fundus photography and ultra-wide fundus photography

    Measured: Baseline and 6 months and 1,2,3,4years

Secondary outcomes (4)
  1. Relationship between the changes of visual function and pathological changes among patients with high myopia

    Relationship between the changes of visual function including best corrected visual acuity and visual field and pathological changes among patients with high myopia

    Measured: Baseline and 6 months and 1,2,3,4years

  2. Structural parameters of anterior segment

    Structural parameters of anterior segment including corneal curvature,lens thickness(LT),etc

    Measured: Baseline and 6 months and 1,2,3,4years

  3. Intraocular pressure(IOP)

    Incidence of elevated intraocular pressure collected by a non-contact tonometer

    Measured: Baseline and 6 months and 1,2,3,4years

  4. Mental state and quality of life

    Mental state and quality of life collected by a questionnaire

    Measured: Baseline and 6 months and 1,2,3,4years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2023
  2. Study start25 Dec 2023 (estimated)
  3. Primary completion1 Sep 2027 (estimated)
  4. Study completion1 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,000 participants (estimated)
Target duration
4 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT06162234
Sponsor's protocol ID
WWDRY2023-K074
Acronym
LOVE-WH
Status last verified
Dec 2023
First submitted
1 Dec 2023
Last updated
27 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of High Myopia, run by Renmin Hospital of Wuhan University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact QY Wu, MD (+86 18672345926, wuqyan@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Myopic optic nerve changes (time frame: Baseline and 6 months and 1,2,3,4years). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in